As House Republicans struggle — again — to decide who will lead them, the clock is ticking on a short-term spending bill that keeps the federal government running only until mid-November.
The VPAS fallout continues – Celltrion pulls high-profile biosimilar from UK market – Pharmaceutical Technology
Celltrion had voiced initial worries about the likely unsustainability of the 2023 VPAS rate long before it was set last December. Credit: Pavel Kapysh /
July 3, 2023